NO882281L - Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.

Info

Publication number
NO882281L
NO882281L NO882281A NO882281A NO882281L NO 882281 L NO882281 L NO 882281L NO 882281 A NO882281 A NO 882281A NO 882281 A NO882281 A NO 882281A NO 882281 L NO882281 L NO 882281L
Authority
NO
Norway
Prior art keywords
alkyl
pyrazinamides
preparation
bromine
hydrogen
Prior art date
Application number
NO882281A
Other languages
English (en)
Norwegian (no)
Other versions
NO882281D0 (no
Inventor
John Anthony Schwartz
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878712365A external-priority patent/GB8712365D0/en
Priority claimed from GB888804983A external-priority patent/GB8804983D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of NO882281D0 publication Critical patent/NO882281D0/no
Publication of NO882281L publication Critical patent/NO882281L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/16Halogen atoms; Nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO882281A 1987-05-26 1988-05-25 Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. NO882281L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712365A GB8712365D0 (en) 1987-05-26 1987-05-26 Aminomethylphenolic pyrazines
GB888804983A GB8804983D0 (en) 1988-03-02 1988-03-02 Heterocyclic compounds

Publications (2)

Publication Number Publication Date
NO882281D0 NO882281D0 (no) 1988-05-25
NO882281L true NO882281L (no) 1988-11-28

Family

ID=26292286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882281A NO882281L (no) 1987-05-26 1988-05-25 Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.

Country Status (14)

Country Link
US (1) US4910202A (fr)
EP (1) EP0293170A1 (fr)
JP (1) JPS6456668A (fr)
KR (1) KR880013904A (fr)
CN (1) CN88103114A (fr)
AU (1) AU1634588A (fr)
DK (1) DK288888A (fr)
FI (1) FI882482A (fr)
GB (1) GB8810933D0 (fr)
HU (1) HU199129B (fr)
NO (1) NO882281L (fr)
PL (1) PL272681A1 (fr)
PT (1) PT87572B (fr)
ZW (1) ZW6388A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810934D0 (en) * 1987-05-26 1988-06-15 Ici America Inc Amides
US5739211A (en) * 1997-02-25 1998-04-14 The Goodyear Tire & Rubber Company Rubber compositions containing a pyrazine amide
EP1131634A2 (fr) * 1998-09-30 2001-09-12 Elan Pharmaceuticals, Inc. Reactifs biologiques et procedes servant a determiner le mecanisme implique dans la generation du peptide beta-amyloide
CA2727196A1 (fr) * 2008-06-10 2009-12-17 Novartis Ag Composes organiques
UY36034A (es) 2014-03-18 2015-09-30 Astrazeneca Ab Derivados de 3,5-diamino-6-cloro-pirazina-2-carboxamida y sales farmaceuticamente aceptables de estos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3305552A (en) * 1965-11-22 1967-02-21 Merck & Co Inc 3-aminopyrazinoic acids and process for their preparation
NL6707566A (fr) * 1966-08-17 1968-02-19
US3555024A (en) * 1968-11-13 1971-01-12 Merck & Co Inc 1-(3-aminopyrazinoyl)semicarbazides,1-(3-aminopyrazinoyl) - thiosemicarbazides,and method for their preparation
US3567725A (en) * 1968-11-20 1971-03-02 Merck & Co Inc Process for preparation of 1h-imidazo-(4,5-b)pyrazin-2-ones
US3577418A (en) * 1969-02-12 1971-05-04 Merck & Co Inc Pyrazinamide derivatives and processes for their preparation
US3544568A (en) * 1969-03-18 1970-12-01 Merck & Co Inc 3-amino-5,6-substituted pyrazinamides
US3809721A (en) * 1970-12-23 1974-05-07 Merck & Co Inc Substituted 2-aminomethyl-4,6-disubstituted phenols
US4041032A (en) * 1974-01-16 1977-08-09 Yamanouchi Pharmaceutical Co., Ltd. Pyrazine derivatives
US3928624A (en) * 1974-04-25 1975-12-23 Merck & Co Inc Phenol compounds in treating pain, fever and inflammation
US4029816A (en) * 1975-11-25 1977-06-14 Merck & Co., Inc. Substituted 2-aminomethyl-6-iodophenols
US4085211A (en) * 1975-12-15 1978-04-18 Merck & Co., Inc. Pyrazinecarboxamides and processes for preparing same
US4115573A (en) * 1977-03-04 1978-09-19 Merck & Co., Inc. N-pyrazinecarbonyl-N'-substituted-sulfamoylguanidine and processes for preparing same
US4272537A (en) * 1980-07-02 1981-06-09 Merck & Co., Inc. 3-Amino-5-substituted-6-halo-N-(4,4-disubstituted-6-substituted-1,3,5-triazin-2-yl)-2-pyrazinecarboxamides
IE52345B1 (en) * 1981-02-02 1987-09-16 Ici Plc Alkanolamine derivatives
EP0086564B1 (fr) * 1982-01-29 1985-11-21 Imperial Chemical Industries Plc Dérivés d'alkanolamine

Also Published As

Publication number Publication date
US4910202A (en) 1990-03-20
HU199129B (en) 1990-01-29
GB8810933D0 (en) 1988-06-15
FI882482A0 (fi) 1988-05-26
CN88103114A (zh) 1988-12-28
DK288888A (da) 1988-11-27
DK288888D0 (da) 1988-05-26
ZW6388A1 (en) 1989-12-20
PT87572A (pt) 1989-05-31
NO882281D0 (no) 1988-05-25
PT87572B (pt) 1992-09-30
AU1634588A (en) 1988-12-01
FI882482A (fi) 1988-11-27
EP0293170A1 (fr) 1988-11-30
JPS6456668A (en) 1989-03-03
PL272681A1 (en) 1989-02-06
KR880013904A (ko) 1988-12-22
HUT47918A (en) 1989-04-28

Similar Documents

Publication Publication Date Title
NO303778B1 (no) Sulfonamid-derivat eller sulfonester-derivat, middel og preparat omfattende et slikt derivat, anvendelse derav samt mellomprodukt
DK0503162T3 (da) Asolderivater, fremgangsmåde til deres fremstilling og deres anvendelse
MY104626A (en) A 1-phenylimidazole derivative and its production and use.
NO954681L (no) Kjemiske forbindelser
NO166126C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinolonkarboksylsyrederivater.
NO883146D0 (no) Anti-inflamatorisk aktive arylderivater og fremgangsmaate for deres fremstilling.
DK519985A (da) Quinoloncarboxylsyrederivater, fremgangsmaade til fremstilling deraf og antibakterielt middel indeholdende saadanne derivater
NO178968C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive aminopyrimidin-karboksamidderivater
NO882281L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
NO952402L (no) Substituerte 6-azaandrostenoner
ES8802040A1 (es) Un procedimiento para la preparacion de fenialquil-2,3-dihidrobenzofuranos y los correspondientes dihidrobenzopiranos
NO922114L (no) Kjemiske forbindelser
FI101882B (fi) Herbisidiset ££(1,3,5-triatsin-2-yyli) aminokarbonyyli|aminosulfonyyli |bentsoehappoesterit, niitä sisältävä valmiste ja niiden käyttö
AU2003232771A1 (en) N-aryl-4,5-diaminopyrazols and dyes containing said compounds
NO871575D0 (no) Fremgangsmaate for fremstilling av 1,5-benztiazepinderivater.
DK160271C (da) Analogifremgangsmaade til fremstilling af 5-halogenvinyl-uracil-derivater
DK428087A (da) Dihydropyridin-5-phosphonsyre-cyclopropylenester
NO913004D0 (no) Syreaddisjonssalter av optisk aktive alaninanilidforbindelser og farmasoeytiske blandinger som inneholder dem.
ES2118828T3 (es) Procedimiento para la obtencion de acidos 2,5-dihidroxifenilaceticos.
DK316986A (da) Kemiske forbindelser, som er phosphodiesterase type iii inhibitorer
HUP0104267A2 (hu) 1,4-Diaril-2-fluor-3-hidroxi-1-butén-származékok és alkalmazásuk 1,4-diaril-2-fluor-1,3-butadién- és 1,4-diaril-2-fluor-2-butén-származékok előállítására
ES2038290T3 (es) Esteres halogenados.
KR970001360A (ko) 피리딘을 함유한 티에노피리미돈 유도체